Biosafety and Bioefficacy Assessment of Human Mesenchymal Stem Cells: What do we Know so Far?
- 6 March 2018
- journal article
- review article
- Published by Taylor & Francis in Regenerative Medicine
- Vol. 13 (2) , 219-232
Abstract
An outstanding amount of resources has been used in research on manipulation of human stem cells, especially mesenchymal stem cells (MSCs), for various clinical applications. However, human MSCs have not been fully utilized in clinical applications due to restrictions with regard to their certain biosafety and bioefficacy concerns, for example, genetic abnormality, tumor formation, induction of host immune response and failure of homing and engraftment. This review summarizes the biosafety and bioefficacy assessment of human MSCs in terms of genetic stability, tumorigenicity, immunogenicity, homing and engraftment. The strategies used to reduce the biosafety concerns and improve the bioefficacy of human MSCs are highlighted. In addition, the approaches that can be implemented to improve their biosafety and bioefficacy assessment are briefly discussed.Keywords
Funding Information
- Frontier Science University of Malaya (RP022C-14AFR)
- University of Malaya Research Grant (RP040B-15HTM)
- Postgraduate Research Grant (PG068-2016A)
This publication has 126 references indexed in Scilit:
- Quantitative and phenotypic analysis of mesenchymal stromal cell graft survival and recognition by microglia and astrocytes in mouse brainImmunobiology, 2013
- miR‐125b Is an Adhesion‐Regulated microRNA that Protects Mesenchymal Stem Cells from AnoikisStem Cells, 2012
- Culture of human mesenchymal stem cells at low oxygen tension improves growth and genetic stability by activating glycolysisCell Death & Differentiation, 2011
- An antibody against SSEA-5 glycan on human pluripotent stem cells enables removal of teratoma-forming cellsNature Biotechnology, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Human Induced Pluripotent Stem Cells Develop Teratoma More Efficiently and Faster Than Human Embryonic Stem Cells Regardless the Site of InjectionStem Cells, 2010
- Deconstructing Stem Cell Tumorigenicity: A Roadmap to Safe Regenerative MedicineStem Cells, 2009
- In vivo fluorescence imaging: a personal perspectiveWIREs Nanomedicine and Nanobiotechnology, 2009
- Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined FactorsCell, 2007
- Adult human mesenchymal stem cell as a target for neoplastic transformationOncogene, 2004